These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 20454512)
1. TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Lafferty-Whyte K; Bilsland A; Hoare SF; Burns S; Zaffaroni N; Cairney CJ; Keith WN Neoplasia; 2010 May; 12(5):405-14. PubMed ID: 20454512 [TBL] [Abstract][Full Text] [Related]
2. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Atkinson SP; Hoare SF; Glasspool RM; Keith WN Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922 [TBL] [Abstract][Full Text] [Related]
3. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells. Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269 [TBL] [Abstract][Full Text] [Related]
4. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317 [TBL] [Abstract][Full Text] [Related]
5. ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs. Zhang F; Wang S; Zhu J J Biol Chem; 2020 Jul; 295(29):10062-10075. PubMed ID: 32518154 [TBL] [Abstract][Full Text] [Related]
6. Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Li W; Zeng J; Li Q; Zhao L; Liu T; Björkholm M; Jia J; Xu D Mol Cancer; 2010 May; 9():132. PubMed ID: 20509972 [TBL] [Abstract][Full Text] [Related]
7. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Casillas MA; Brotherton SL; Andrews LG; Ruppert JM; Tollefsbol TO Gene; 2003 Oct; 316():57-65. PubMed ID: 14563552 [TBL] [Abstract][Full Text] [Related]
9. PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells. Toaldo C; Pizzimenti S; Cerbone A; Pettazzoni P; Menegatti E; Daniela B; Minelli R; Giglioni B; Dianzani MU; Ferretti C; Barrera G J Cell Mol Med; 2010 Jun; 14(6A):1347-57. PubMed ID: 19912441 [TBL] [Abstract][Full Text] [Related]
10. siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells. Hao H; Nancai Y; Lei F; Xiong W; Wen S; Guofu H; Yanxia W; Hanju H; Qian L; Hong X J Exp Clin Cancer Res; 2008 Aug; 27(1):27. PubMed ID: 18694522 [TBL] [Abstract][Full Text] [Related]
11. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Chang JT; Yang HT; Wang TC; Cheng AJ Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690 [TBL] [Abstract][Full Text] [Related]
12. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213 [TBL] [Abstract][Full Text] [Related]
13. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis. Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line. Ogretmen B; Kraveka JM; Schady D; Usta J; Hannun YA; Obeid LM J Biol Chem; 2001 Aug; 276(35):32506-14. PubMed ID: 11441001 [TBL] [Abstract][Full Text] [Related]
15. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma. Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929 [TBL] [Abstract][Full Text] [Related]
16. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Moon DO; Kim MO; Lee JD; Choi YH; Kim GY Cancer Lett; 2009 Dec; 286(2):172-9. PubMed ID: 19560862 [TBL] [Abstract][Full Text] [Related]
17. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells. Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431 [TBL] [Abstract][Full Text] [Related]
18. A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Lafferty-Whyte K; Cairney CJ; Will MB; Serakinci N; Daidone MG; Zaffaroni N; Bilsland A; Keith WN Oncogene; 2009 Oct; 28(43):3765-74. PubMed ID: 19684619 [TBL] [Abstract][Full Text] [Related]
19. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Guilleret I; Benhattar J Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633 [TBL] [Abstract][Full Text] [Related]
20. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Jagadeesh S; Kyo S; Banerjee PP Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]